Verano Holdings (VRNO) Other Working Capital Changes (2021 - 2026)
Verano Holdings' (VRNO) quarterly Other Working Capital Changes came in at $3.6 million in Q1 2026, down 21.44% year-on-year from $4.5 million in Q1 2025, and down 66.06% on a QoQ basis from $10.5 million in Q4 2025.
Verano Holdings (VRNO) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Other Working Capital Changes data on file, last reported at $3.6 million in Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 21.44% year-over-year to $3.6 million in Q1 2026; TTM through Mar 2026 was $17.8 million, a 6.44% decrease from a year earlier, with the FY2025 full-year figure at $18.8 million, up 19.68% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $3.6 million, down from $10.5 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for VRNO reached as high as $22.4 million in Q4 2022 and fell as low as -$10.1 million in Q1 2024.
- Historically, Other Working Capital Changes has averaged $893117.6 across 5 years, with a median of -$47000.0 in 2023.
- Across the five-year window, Other Working Capital Changes plunged 93.56% in 2022 and surged 1102.52% in 2023, its largest moves.
- Year by year, Other Working Capital Changes stood at $5.4 million in 2022, then sank by 62.19% to $2.0 million in 2023, then surged by 260.46% to $7.3 million in 2024, then jumped by 43.71% to $10.5 million in 2025, then tumbled by 66.06% to $3.6 million in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were $3.6 million in Q1 2026, $10.5 million in Q4 2025, and $854000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.61 Mn |
| Mar 31, 2026 | -8.61 Mn |
| Mar 31, 2026 | -8.61 Mn |
| Dec 31, 2025 | 5.88 Mn |
| Dec 31, 2025 | 5.88 Mn |
| Dec 31, 2025 | 5.88 Mn |
| Sep 30, 2025 | -3.48 Mn |
| Sep 30, 2025 | -3.48 Mn |
| Sep 30, 2025 | -3.48 Mn |
| Jun 30, 2025 | 561,000.00 |
| Jun 30, 2025 | 561,000.00 |
| Jun 30, 2025 | 561,000.00 |
| Mar 31, 2025 | 1.32 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | -1.49 Mn |
| Dec 31, 2024 | -1.49 Mn |
| Dec 31, 2024 | -1.49 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.56 Mn |